MIST vs. NVDA
Compare and contrast key facts about Milestone Pharmaceuticals Inc. (MIST) and NVIDIA Corporation (NVDA).
Performance
MIST vs. NVDA - Performance Comparison
Loading graphics...
MIST vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MIST Milestone Pharmaceuticals Inc. | -41.09% | -14.41% | 41.32% | -57.83% | -39.54% | -2.24% | -58.15% | 4.16% |
NVDA NVIDIA Corporation | -6.48% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 38.65% |
Fundamentals
MIST:
$99.82M
NVDA:
$4.26T
MIST:
-$1.10
NVDA:
$4.90
MIST:
59.84
NVDA:
19.80
MIST:
2.39
NVDA:
27.09
MIST:
$1.44M
NVDA:
$215.94B
MIST:
-$80.00K
NVDA:
$153.46B
MIST:
-$62.14M
NVDA:
$144.55B
Returns By Period
In the year-to-date period, MIST achieves a -41.09% return, which is significantly lower than NVDA's -6.48% return.
MIST
- 1D
- 17.82%
- 1M
- -30.41%
- YTD
- -41.09%
- 6M
- -40.50%
- 1Y
- 48.73%
- 3Y*
- -32.91%
- 5Y*
- -27.76%
- 10Y*
- —
NVDA
- 1D
- 5.59%
- 1M
- -1.57%
- YTD
- -6.48%
- 6M
- -6.52%
- 1Y
- 60.95%
- 3Y*
- 84.54%
- 5Y*
- 66.14%
- 10Y*
- 69.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MIST vs. NVDA — Risk / Return Rank
MIST
NVDA
MIST vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Milestone Pharmaceuticals Inc. (MIST) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MIST | NVDA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.57 | 1.48 | -0.91 |
Sortino ratioReturn per unit of downside risk | 1.27 | 2.17 | -0.90 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.27 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | 0.54 | 2.92 | -2.39 |
Martin ratioReturn relative to average drawdown | 1.24 | 7.39 | -6.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MIST | NVDA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.57 | 1.48 | -0.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | 1.29 | -1.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.40 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.29 | 0.61 | -0.91 |
Correlation
The correlation between MIST and NVDA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MIST vs. NVDA - Dividend Comparison
MIST has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIST Milestone Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Drawdowns
MIST vs. NVDA - Drawdown Comparison
The maximum MIST drawdown since its inception was -97.60%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for MIST and NVDA.
Loading graphics...
Drawdown Indicators
| MIST | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.60% | -89.72% | -7.88% |
Max Drawdown (1Y)Largest decline over 1 year | -65.76% | -20.21% | -45.55% |
Max Drawdown (5Y)Largest decline over 5 years | -93.13% | -66.34% | -26.79% |
Max Drawdown (10Y)Largest decline over 10 years | — | -66.34% | — |
Current DrawdownCurrent decline from peak | -95.62% | -15.76% | -79.86% |
Average DrawdownAverage peak-to-trough decline | -77.88% | -36.40% | -41.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.51% | 7.99% | +20.52% |
Volatility
MIST vs. NVDA - Volatility Comparison
Milestone Pharmaceuticals Inc. (MIST) has a higher volatility of 36.20% compared to NVIDIA Corporation (NVDA) at 10.46%. This indicates that MIST's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MIST | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 36.20% | 10.46% | +25.74% |
Volatility (6M)Calculated over the trailing 6-month period | 55.27% | 25.91% | +29.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.55% | 41.44% | +45.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.69% | 51.74% | +24.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 105.91% | 49.85% | +56.06% |
Financials
MIST vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Milestone Pharmaceuticals Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities